Cheaper isn’t always better, and Prescription Drugs are No Exception

Earlier this month, the Patented Medicine Prices Review Board published new regulations that could see drug prices cut by up to 20 per cent. Taking a page from United States President Donald Trump, Prime Minister Justin Trudeau’s government has adopted a reductive, fair-means-cheap pricing equation. The effects may be damaging for the pharmaceutical industry, Canadian innovators in life sciences, our patients, and the future of our health-care system. To read the full article in The Hill Times, click here.